How to Reduce Masseter Muscle Size
Reducing the size of the masseter muscle—the thick, rectangular muscle responsible for jaw clenching and chewing—can be pursued for aesthetic reasons, such as softening a square or overly prominent ja
Reducing the size of the masseter muscle—the thick, rectangular muscle responsible for jaw clenching and chewing—can be pursued for aesthetic reasons, such as softening a square or overly prominent jawline, or for functional concerns like bruxism-related hypertrophy or temporomandibular joint (TMJ) discomfort. Unlike skeletal muscle in limbs, the masseter is highly responsive to repetitive mechanical loading; chronic clenching, grinding (bruxism), or frequent consumption of tough, chewy foods can lead to adaptive hypertrophy.
Non-invasive approaches form the first-line strategy. Behavioral modification—including conscious relaxation of the jaw, avoiding gum chewing, and limiting hard or fibrous foods—helps reduce neuromuscular stimulation. Dental interventions, such as custom-fitted occlusal splints, mitigate nocturnal bruxism and decrease involuntary muscle activity during sleep. Physical therapies like manual massage, ultrasound, or low-level laser therapy may offer adjunctive benefits, though high-quality evidence remains limited.
For patients seeking more pronounced or rapid reduction, botulinum toxin type A (e.g., onabotulinumtoxinA) injections into the masseter are widely used off-label and supported by robust clinical data. Administered bilaterally into the mid-belly of the muscle, the neurotoxin induces temporary chemodenervation, leading to dose-dependent atrophy over 4–8 weeks. Effects typically last 4–6 months, with repeated treatments often yielding cumulative and longer-lasting results. Safety profiles are favorable when performed by experienced clinicians; potential adverse effects include transient asymmetry, mild dysphagia, or unintended diffusion to adjacent muscles—emphasizing the need for precise anatomical knowledge and injection technique.
Surgical reduction—such as partial resection or marginal mandibulectomy—is reserved for severe, refractory cases and carries significantly higher risks, including nerve injury, contour irregularities, and prolonged recovery. It is rarely indicated solely for cosmetic purposes given the efficacy and safety of less invasive alternatives.
Any intervention should begin with a comprehensive evaluation by a qualified healthcare provider—including dental, oral and maxillofacial, or aesthetic medicine specialists—to rule out underlying pathology (e.g., TMJ disorders, myofascial pain syndromes, or neurological conditions) and tailor management to individual anatomy, function, and goals.